On July 1st, 2025, ABzero successfully closed a €190,000 investment round, aimed at strengthening the company’s organizational structure and supporting the next stages of technological and commercial development.
Part of the investment was allocated to internal restructuring, optimizing processes, enhancing the team, and increasing overall efficiency in preparation for upcoming challenges. This step was necessary to align the company operational framework with its medium- and long-term strategic objectives.
The round reflects investors’ confidence in ABzero vision and the technological value of the ABzero system, our proprietary platform for the autonomous, tracked, and secure delivery of blood components and critical medical supplies. The system has a concrete impact on the speed, reliability, and sustainability of healthcare services.
The operation was completed with a pre-money valuation of €4,600,000, confirming the technical soundness, market positioning, and industrial potential of the project.
This milestone comes at a particularly significant time for ABzero, which has also been awarded the prestigious MOST – Mobility and Sustainability Talent Prize, promoted by the National Center for Sustainable Mobility (MOST) and awarded at the MAUTO – National Automobile Museum in Turin. This recognition highlights the innovative and sustainable impact of the ABzero system in the field of medical mobility.
We thank all those who continue to believe in our mission: revolutionizing medical logistics by making it more intelligent, autonomous, and sustainable through innovation.